Revel Pharmaceuticals Alternatives & Competitors
7 companies similar to Revel Pharmaceuticals — Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to...
Companies similar to Revel Pharmaceuticals
Lento Bio
Restoring Tissue Flexibility and Function in Chronic Diseases of Aging
Elixir Pharmaceuticals
Pioneering the future of metabolic disease treatment by harnessing genetic interactions to...
Amplifier Therapeutics
Harnessing the broad therapeutic applications of AMPK activation
Rejuvenate Bio
Targeting the core drivers of chronic age-related diseases to reverse pre-existing conditi...
Track all Revel Pharmaceuticals competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Opterion Health AG
Renewing Renal Care
CaSRevolution
A new hope for patients affected by Alzheimer’s disease
Cytochroma
Specializing in advanced solutions for CKD patients with vitamin D insufficiency and hyper...
About Revel Pharmaceuticals
Revel Pharmaceuticals is a biotechnology startup headquartered in the United States. Established in 2019, the company focuses on commercializing therapeutic enzymes to degrade age-associated molecule damage, particularly targeting Advanced Glycation End Products (AGEs). These compounds accumulate on long-lived proteins...
Therapeutic Enzymes, AGEs, Advanced Glycation End Products, Diseases Of Aging, Osteoarthritis, Kidney Disease, Cardiovascular Disease, Skin Aging, Diabetes Complications, Pharmaceuticals, Enzyme Therapy, Biotech Startups, Aging Research, Medical Advancements
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Revel Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Revel Pharmaceuticals on 12 Sep 2024. The 7 companies listed here were last checked between 21 Jun 2024 and 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.